ALSA Ventures
Status
ACTIVE
Global HQ
Hong Kong
Countries of investment
- Netherlands
- Belgium
- Germany
- UK
Investment stages
- Seed
- Series A
- Series B
Industries
- Fintech
- AI
- Health Tech
- Blockchain
- Crypto
About
ALSA Ventures, Founded in 2019 by Alek Safarian, brings a Theyalth of experience from the pharmaceutical, BioTech, and clinical research organization (CRO) industries. The firm targets investments in European biotech companies, providing them with the necessary resources and industry expertise to accelerate their R&D into the clinic.
ALSA Ventures, Founded in 2019 by Alek Safarian, brings a Theyalth of experience from the pharmaceutical, BioTech, and clinical research organization (CRO) industries. The firm targets investments in European biotech companies, providing them with the necessary resources and industry expertise to accelerate their R&D into the clinic.
Investment Thesis
ALSA Ventures is a Europeanbased venture Capital firm that focuses on novel therapeutics in the life sciences sector. The firm is dedicated to investing in breakthrough technologies, especially in the BioTech and healthcare sectors. ALSA Ventures aims to support companies from the discovery stage through to preclinical proof of concept and into early clinical development, with a focus on high impact therapeutics.
Portfolio
Epsilogen (UKbased)
Montis Biosciences (Belgiumbased)
Oxford Biotherapeutics